(Q1078392)

indapamide (English)

3 October 2016

C₁₆H₁₆ClN₃O₃S

1 reference

indapamide (English)

19 November 2016

CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N

1 reference

indapamide (English)

19 November 2016

2.5 milligram

route of administration

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=C03BA11

medical condition treated

1 reference

13 December 2016

1 reference

13 December 2016

congestive heart failure

1 reference

13 December 2016

arterial hypertension

2 references

13 December 2016

Drug Indications Extracted from FAERS

Food and Drug Administration

2 October 2018

congestive heart failure

start time

22 July 1998

approved by

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/F089I0511L

https://www.drugs.com/pro/indapamide.html

arterial hypertension

start time

22 July 1998

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/F089I0511L

https://www.drugs.com/pro/indapamide.html

significant drug interaction

desmopressin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pulseless electrical activity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cardiotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lisinopril dihydrate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quinapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ramipril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

captopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

enalapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trandolapril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosinopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

perindopril

1 reference

A reference set of clinically relevant adverse drug-drug interactions

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vomiting

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nausea

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

long QT syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

hypomagnesemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

thirst

1 reference

A reference set of clinically relevant adverse drug-drug interactions

asthenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

intention tremor

1 reference

A reference set of clinically relevant adverse drug-drug interactions

delirium

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

hyperglycemia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

bromocriptine

increased insulin requirement

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

solute carrier family 12 member 3

subject has role

reaction inhibitor

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL406

pregnancy category

Australian pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category B

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

antihypertensive drug

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D007190

Sodium Chloride Symporter Inhibitors

15 March 2018

1 reference

InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

Medical Subject Headings

15 March 2018

Indapamide

0 references

Identifiers

InChI

1 reference

indapamide (English)

19 November 2016

2 references

indapamide (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

26807-65-8

2 references

indapamide (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=26807-65-8

10 April 2021

1 reference

Indapamide (English)

19 November 2016

2 references

indapamide (English)

19 November 2016

Reaxys registry number

1604026

1 reference

indapamide (English)

3 October 2016

mapping relation type

2 references

INDAPAMIDE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

1 reference

INDAPAMIDE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU111101

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU111102

0 references

MSBNK-Athens_Univ-AU111103

0 references

MSBNK-Athens_Univ-AU111104

0 references

MSBNK-Athens_Univ-AU111105

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA000787

0 references

MSBNK-Waters-WA000788

0 references

MSBNK-Waters-WA000789

0 references

MSBNK-Waters-WA000790

0 references

MSBNK-Waters-WA000791

0 references

MSBNK-Waters-WA000792

0 references

MSBNK-Waters-WA000793

0 references

SPLASH

splash10-001i-0900000000-235673a939e2e7d8c5e3

0 references

splash10-0159-0900000000-a843660d42ffb01666fe

0 references

splash10-001i-0900000000-cfee205b361c580e3631

0 references

splash10-00lr-0900000000-a6d8ff4d769ea09e8073

0 references

splash10-001i-0901000000-a76c5fd366807c180552

0 references

splash10-001i-0900000000-574a71dcc7f0b3f74693

0 references

splash10-001i-1900000000-ab046a8849c404d9b308

0 references

splash10-00l6-4900000000-93f1cc6465f329fd111e

0 references

splash10-00kf-8900000000-0e98ece38603802699f7

0 references

splash10-014l-9600000000-c7e6e85faab95871c46d

0 references

splash10-014l-9300000000-d9a4af4e617331f29e98

0 references

splash10-014l-9100000000-60cb951d344ed0385fc6

0 references

splash10-014u-9000000000-d07d645a1ccd383e7a1b

0 references

splash10-03di-0009000000-ed04e0a5871badc8b166

0 references

splash10-03di-1729000000-15aecb441ef4febfe526

0 references

splash10-000i-2910000000-b72aeba8db62ebdf9c17

0 references

splash10-004r-6900000000-f819fedd1ac654d46dd4

0 references

splash10-004i-9300000000-164a2972880c967d2195

0 references

splash10-004i-9100000000-d18afa355f919614b652

0 references

splash10-01t9-9000000000-9d9e98925e9105738992

0 references

splash10-03fr-9000000000-5e7568f4efd1730f47b9

0 references

splash10-03di-9000000000-ecfffadaaa03b447eaf5

0 references

splash10-001i-2900000000-10b16fdb4047a076cc32

0 references

DSSTox substance ID

DTXSID7044633

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

indapamide (English)

ECHA Substance Infocard ID

19 November 2016

100.043.633

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Indapamide (English)

CAS no.: 26807-65-8 (English)

1 reference

Guide to Pharmacology Ligand ID

Indapamide (English)

publication date

17 November 2015

7203

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7203

indapamide (English)

19 November 2016

Indapamide

0 references

0 references

0 references

0 references

1 reference

indapamide (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014946

2 references

based on heuristic

inferred from InChIKey

2 references

indapamide (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

indapamide (English)

19 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

indapamide (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

archive URL

https://web.archive.org/web/20220125070108/https://docs.openalex.org/download-snapshot/snapshot-data-format

25 January 2022

1 reference

inferred by common MeSH mappings on source and on Wikidata

indapamide (English)

19 November 2016

1 reference

25 May 2023

0 references

WordNet 3.1 Synset ID

03572505-n

1 reference